Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Adaptimmune Therapeutics PLC publishes a filing, an earnings call transcript or a press release.

Get ADAPY alerts

About William Bertrand

William Bertrand is recorded as COO at Adaptimmune Therapeutics PLC (ADAPY). The newest filing on record that lists William Bertrand as COO at Adaptimmune Therapeutics PLC (ADAPY) is dated April 25, 2025. The proxy statement of Adaptimmune Therapeutics PLC reports total compensation of $1,215,100 for William Bertrand in fiscal 2023, including a base salary of $468,179. Disclosed compensation is on record for 5 fiscal years. Adaptimmune Therapeutics PLC is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Adaptimmune Therapeutics PLC includes Adrian Rawcliffe (CEO and Board Member), David M. Mott (Chairman), Christopher Hill (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Adaptimmune Therapeutics PLC

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Adaptimmune Therapeutics PLC (ADAPY) $468,179 $1,215,100
2022 Adaptimmune Therapeutics PLC (ADAPY) $468,179 $1,388,271
2021 Adaptimmune Therapeutics PLC (ADAPY) $456,760 $1,756,188
2020 Adaptimmune Therapeutics PLC (ADAPY) $443,456 $1,551,113
2019 Adaptimmune Therapeutics PLC (ADAPY) $432,640 $1,371,180

Recent activity

No call appearances or filed executive changes recorded yet.